| 000 | 01542 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518085739.0 | ||
| 264 | 0 | _c20200630 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1096-9071 | ||
| 024 | 7 |
_a10.1002/jmv.25722 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSun, Pengfei | |
| 245 | 0 | 0 |
_aUnderstanding of COVID-19 based on current evidence. _h[electronic resource] |
| 260 |
_bJournal of medical virology _c06 2020 |
||
| 300 |
_a548-551 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdenosine Monophosphate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 |
_aAlanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBetacoronavirus _xdrug effects |
| 650 | 0 | 4 | _aCOVID-19 |
| 650 | 0 | 4 |
_aChina _xepidemiology |
| 650 | 0 | 4 |
_aChiroptera _xvirology |
| 650 | 0 | 4 |
_aCommunicable Disease Control _xorganization & administration |
| 650 | 0 | 4 |
_aCoronavirus Infections _xdiagnosis |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOseltamivir _xtherapeutic use |
| 650 | 0 | 4 | _aPandemics |
| 650 | 0 | 4 |
_aPneumonia, Viral _xdiagnosis |
| 650 | 0 | 4 | _aSARS-CoV-2 |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aLu, Xiaosheng | |
| 700 | 1 | _aXu, Chao | |
| 700 | 1 | _aSun, Wenjuan | |
| 700 | 1 | _aPan, Bo | |
| 773 | 0 |
_tJournal of medical virology _gvol. 92 _gno. 6 _gp. 548-551 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmv.25722 _zAvailable from publisher's website |
| 999 |
_c30671362 _d30671362 |
||